Search
for

    Sort by

    Research 61–90 of 1000+

    1. Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids Nature Cell Biology · 2021 · 36 citations
    2. Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 20 citations
    3. 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men medRxiv (Cold Spring Harbor Laboratory) · 2020 · 5 citations
    4. Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment Journal of Infection · 2022 · 3 citations
    5. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab Journal of Endocrinological Investigation · 2020 · 198 citations
    6. Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation The Egyptian Journal of Internal Medicine · 2022 · 12 citations
    7. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system 2021 · 6 citations
    8. Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature 2024
    9. Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury Scientific Reports · 2021 · 5 citations
    10. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies European Journal of Clinical Pharmacology · 2020 · 77 citations
    11. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population Scientific Reports · 2021 · 44 citations
    12. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia International Journal of Infectious Diseases · 2021 · 38 citations
    13. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2 Journal of Medical Virology · 2021 · 30 citations
    14. Candidate genes of SARS-CoV-2 gender susceptibility Scientific Reports · 2021 · 27 citations
    15. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19 Journal of infection and chemotherapy · 2021 · 21 citations
    16. Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development Frontiers in Pharmacology · 2022 · 17 citations
    17. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Reviews in endocrine and metabolic disorders · 2021 · 14 citations
    18. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia Medical Gas Research · 2023 · 13 citations
    19. Sex hormones in SARS-CoV-2 susceptibility: key players or confounders? Nature Reviews Endocrinology · 2022 · 8 citations
    20. Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy Dermatology and Therapy · 2021 · 7 citations
    21. Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 7 citations
    22. Androgens in SARS-CoV-2 Coronavirus Infections Physiological Research · 2021 · 5 citations
    23. Telogen effluvium in SARS‐CoV‐2 infection: Histological aspects Journal of the European Academy of Dermatology and Venereology · 2023 · 4 citations
    24. From bedside to bench: regulation of host factors in SARS-CoV-2 infection Experimental and Molecular Medicine · 2021 · 4 citations
    25. Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations Journal of Infection · 2022 · 3 citations
    26. Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 3 citations
    27. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells PLoS Pathogens · 2022 · 1 citations
    28. NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE Journal of Experimental Biology and Agricultural Sciences · 2020 · 1 citations
    29. A narrative review of SARS-CoV-2 variants and long COVID Journal of Thoracic Disease · 2026
    30. Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management Diseases · 2025